140 related articles for article (PubMed ID: 27997032)
41. Editorial for "Deep Learning for Noninvasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging".
Bonacchi R; De Meo E
J Magn Reson Imaging; 2023 Sep; 58(3):862-863. PubMed ID: 36661197
[No Abstract] [Full Text] [Related]
42. Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging.
Liu T; Cheng G; Kang X; Xi Y; Zhu Y; Wang K; Sun C; Ye J; Li P; Yin H
Neuroradiology; 2018 Jul; 60(7):693-702. PubMed ID: 29777252
[TBL] [Abstract][Full Text] [Related]
43. Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas.
Kambhampati M; Panditharatna E; Yadavilli S; Saoud K; Lee S; Eze A; Almira-Suarez MI; Hancock L; Bonner ER; Gittens J; Stampar M; Gaonkar K; Resnick AC; Kline C; Ho CY; Waanders AJ; Georgescu MM; Rance NE; Kim Y; Johnson C; Rood BR; Kilburn LB; Hwang EI; Mueller S; Packer RJ; Bornhorst M; Nazarian J
Sci Rep; 2020 Jul; 10(1):10954. PubMed ID: 32616776
[TBL] [Abstract][Full Text] [Related]
44. Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.
Pratt D; Natarajan SK; Banda A; Giannini C; Vats P; Koschmann C; Mody R; Chinnaiyan A; Venneti S
Acta Neuropathol; 2018 Feb; 135(2):299-301. PubMed ID: 29302777
[No Abstract] [Full Text] [Related]
45. Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.
Tauziède-Espariat A; Saffroy R; Pagès M; Pallud J; Legrand L; Besnard A; Lacombe J; Lot G; Borha A; Tazi S; Adle-Biassette H; Polivka M; Lechapt E; Varlet P
Clin Neuropathol; 2018; 37(5):209-216. PubMed ID: 29809131
[TBL] [Abstract][Full Text] [Related]
46. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter.
Ramnarayan R; Dodd S; Das K; Heidecke V; Rainov NG
J Neurol Sci; 2007 Sep; 260(1-2):49-56. PubMed ID: 17475281
[TBL] [Abstract][Full Text] [Related]
47. Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature.
Kraus TFJ; Machegger L; Pöppe J; Zellinger B; Dovjak E; Schlicker HU; Schwartz C; Ladisich B; Spendel M; Kral M; Reinhardt A; Winkler PA; Sotlar K
Brain Tumor Pathol; 2020 Jul; 37(3):89-94. PubMed ID: 32451719
[TBL] [Abstract][Full Text] [Related]
48. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
[TBL] [Abstract][Full Text] [Related]
49. Familial mixed oligodendrocytic-astrocytic gliomas.
Leblanc R; Lozano A; Robitaille Y
Neurosurgery; 1986 Apr; 18(4):480-2. PubMed ID: 3703224
[TBL] [Abstract][Full Text] [Related]
50. Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.
Daoud EV; Rajaram V; Cai C; Oberle RJ; Martin GR; Raisanen JM; White CL; Foong C; Mickey BE; Pan E; Hatanpaa KJ
J Neuropathol Exp Neurol; 2018 Apr; 77(4):302-311. PubMed ID: 29444279
[TBL] [Abstract][Full Text] [Related]
51. Diffuse Midline Glioma With Osseous Metastases at Diagnosis: A Case Report.
Bhatt NS; Houser K; Belongia M; Ellison DW; Foy A; Jarzembowski J; Kelly T; Maheshwari M; Suchi M; Knipstein J
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e673-e676. PubMed ID: 31568066
[TBL] [Abstract][Full Text] [Related]
52. Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.
Ryall S; Krishnatry R; Arnoldo A; Buczkowicz P; Mistry M; Siddaway R; Ling C; Pajovic S; Yu M; Rubin JB; Hukin J; Steinbok P; Bartels U; Bouffet E; Tabori U; Hawkins C
Acta Neuropathol Commun; 2016 Aug; 4(1):93. PubMed ID: 27577993
[TBL] [Abstract][Full Text] [Related]
53. CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response.
Stallard S; Savelieff MG; Wierzbicki K; Mullan B; Miklja Z; Bruzek A; Garcia T; Siada R; Anderson B; Singer BH; Hashizume R; Carcaboso AM; McMurray KQ; Heth J; Muraszko K; Robertson PL; Mody R; Venneti S; Garton H; Koschmann C
Acta Neuropathol Commun; 2018 Aug; 6(1):80. PubMed ID: 30111355
[No Abstract] [Full Text] [Related]
54. H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.
Gielen GH; Gessi M; Hammes J; Kramm CM; Waha A; Pietsch T
Am J Clin Pathol; 2013 Mar; 139(3):345-9. PubMed ID: 23429371
[TBL] [Abstract][Full Text] [Related]
55. Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis.
Hayashi S; Kitamura Y; Hirose Y; Yoshida K; Sasaki H
J Neurooncol; 2017 Mar; 132(1):119-126. PubMed ID: 28025770
[TBL] [Abstract][Full Text] [Related]
56. Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas.
Cao WD; Kawai N; Miyake K; Zhang X; Fei Z; Tamiya T
Brain Tumor Pathol; 2014 Jan; 31(1):1-10. PubMed ID: 23358800
[TBL] [Abstract][Full Text] [Related]
57. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
[TBL] [Abstract][Full Text] [Related]
58. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
[TBL] [Abstract][Full Text] [Related]
59. Characterization of gliomas: from morphology to molecules.
Ferris SP; Hofmann JW; Solomon DA; Perry A
Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
[TBL] [Abstract][Full Text] [Related]
60. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma.
Tsugu A; Kijima H; Yamazaki H; Ohnishi Y; Takamiya Y; Abe Y; Ueyama Y; Sato O; Tamaoki N; Nakamura M
Anticancer Res; 1997; 17(3C):2225-32. PubMed ID: 9216693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]